322 related articles for article (PubMed ID: 27613494)
1. Differential diagnosis of left ventricular hypertrophy: usefulness of multimodality imaging and tissue characterization with cardiac magnetic resonance.
Izgi C; Vassiliou V; Baksi AJ; Prasad SK
Echocardiography; 2016 Nov; 33(11):1765-1768. PubMed ID: 27613494
[TBL] [Abstract][Full Text] [Related]
2. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.
Windram JD; Benson LN; Dragelescu A; Yoo SJ; Mertens L; Wong D; Grosse-Wortmann L
Congenit Heart Dis; 2015; 10(6):E258-67. PubMed ID: 26193909
[TBL] [Abstract][Full Text] [Related]
4. Multimodality Imaging Assessment of Fabry Disease.
Tower-Rader A; Jaber WA
Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009013. PubMed ID: 31718277
[TBL] [Abstract][Full Text] [Related]
5. Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: Importance of multi-modality imaging.
Kherada N; Vinardell JM; Mihos CG; Santana O
Echocardiography; 2017 Sep; 34(9):1392-1395. PubMed ID: 28573739
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Magnetic Resonance for the Differentiation of Left Ventricular Hypertrophy.
Burrage MK; Ferreira VM
Curr Heart Fail Rep; 2020 Oct; 17(5):192-204. PubMed ID: 32844347
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
Bois JP; Geske JB; Foley TA; Ommen SR; Pellikka PA
Am J Cardiol; 2017 Feb; 119(4):643-650. PubMed ID: 27956002
[TBL] [Abstract][Full Text] [Related]
9. Transient left ventricular wall thickening in a 14-year-old girl with influenza A myocarditis.
Wittlieb-Weber CA; Harris MA; Rossano JW
Cardiol Young; 2015 Jan; 25(1):187-90. PubMed ID: 24480544
[TBL] [Abstract][Full Text] [Related]
10. T-wave inversions related to left ventricular basal hypertrophy and myocardial fibrosis in non-apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
Chen X; Zhao S; Zhao T; Lu M; Yin G; Jiang S; Prasad S
Eur J Radiol; 2014 Feb; 83(2):297-302. PubMed ID: 24332848
[TBL] [Abstract][Full Text] [Related]
11. Merging strain-echo measurements with late gadolinium enhancement at cardiac MRI: An upcoming chance for advanced functional assessment of fibrosis in hypertrophic cardiomyopathy?
de Gregorio C; Di Bella G
Int J Cardiol; 2016 Jan; 203():632-4. PubMed ID: 26590884
[No Abstract] [Full Text] [Related]
12. Comparison of Cardiac Magnetic Resonance Imaging and Echocardiography in Assessment of Left Ventricular Hypertrophy in Fabry Disease.
Hazari H; Belenkie I; Kryski A; White JA; Oudit GY; Thompson R; Fung T; Dehar N; Khan A
Can J Cardiol; 2018 Aug; 34(8):1041-1047. PubMed ID: 29935990
[TBL] [Abstract][Full Text] [Related]
13. Histologically Proven Myocardial Carcinoid Metastases: The Value of Multimodality Imaging.
Studer Bruengger AA; Wechalekar K; Khattar R; Rosen SD; Robertus JL; Chau I; Morganstein D; Rosendahl U; Lyon A; Mohiaddin R
Can J Cardiol; 2017 Oct; 33(10):1336.e9-1336.e12. PubMed ID: 28867261
[TBL] [Abstract][Full Text] [Related]
14. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
Sado DM; White SK; Piechnik SK; Banypersad SM; Treibel T; Captur G; Fontana M; Maestrini V; Flett AS; Robson MD; Lachmann RH; Murphy E; Mehta A; Hughes D; Neubauer S; Elliott PM; Moon JC
Circ Cardiovasc Imaging; 2013 May; 6(3):392-8. PubMed ID: 23564562
[TBL] [Abstract][Full Text] [Related]
15. A Challenging Differential Diagnosis: Distinguishing between Endomyocardial Fibrosis and Apical Hypertrophic Cardiomyopathy.
Maia CP; Gali LG; Schmidt A; de Almeida Filho OC; Santos MK; Saraiva LA; Rodrigues AJ; Maciel BC; Romano MM
Echocardiography; 2016 Jul; 33(7):1080-4. PubMed ID: 27144839
[TBL] [Abstract][Full Text] [Related]
16. The Role of Multimodality Imaging in Right Ventricular Failure.
Wang TKM; Jellis C
Cardiol Clin; 2020 May; 38(2):203-217. PubMed ID: 32284097
[TBL] [Abstract][Full Text] [Related]
17. Role of multimodality imaging in the diagnosis and treatment of hypertrophic cardiomyopathy.
Koss E; Garcia MJ
Semin Roentgenol; 2012 Jul; 47(3):253-61. PubMed ID: 22657115
[No Abstract] [Full Text] [Related]
18. Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease.
Masarone D; Duro G; Dellegrottaglie S; Colomba P; Rubino M; Cirillo A; Pisani A; Caiazza M; Elliott PM; Calabrò P; Pacileo G; Limongelli G
Future Cardiol; 2017 Nov; 13(6):521-527. PubMed ID: 28936893
[TBL] [Abstract][Full Text] [Related]
19. Fabry disease in cardiology practice: Literature review and expert point of view.
Hagège A; Réant P; Habib G; Damy T; Barone-Rochette G; Soulat G; Donal E; Germain DP
Arch Cardiovasc Dis; 2019 Apr; 112(4):278-287. PubMed ID: 30826269
[TBL] [Abstract][Full Text] [Related]
20. Different Clinical Presentation and Tissue Characterization in a Monozygotic Twin Pair with MYH7 Mutation-Related Hypertrophic Cardiomyopathy.
Wang J; Li W; Han Y; Chen Y
Int Heart J; 2019 Mar; 60(2):477-481. PubMed ID: 30745532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
